GO:0060412 ventricular septum morphogenesis: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060412 ventricular septum morphogenesis is the biological process that builds and organizes the ventricular septum, the muscular and membranous wall separating the left and right ventricles of the heart.
• The process requires coordinated contributions from endocardium, myocardium, and neural crest-derived mesenchyme, and disruption of any of these compartments can cause congenital heart defects.
• Key molecular players include connexin43 (GJA1), Hey bHLH transcription factors, and Slit-Robo signaling components, all of which have been linked to ventricular septation in animal models.
• Failure of ventricular septum morphogenesis causes ventricular septal defects (VSDs), the most common congenital heart malformation, and is also relevant to fetal pulmonary valve stenosis or atresia with intact ventricular septum.
• Experimental study of this process uses chick and mouse embryos, lineage tracing, conditional knockout, and imaging of the developing heart.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) now allow precise testing of candidate genes in ventricular septum morphogenesis.
Description
Ventricular septum morphogenesis (GO:0060412) is the developmental process in which the ventricular septum is generated and organized, physically separating the lower chambers of the heart. This process is essential for the parallel pulmonary and systemic circulations that define the mature mammalian heart, and its failure produces ventricular septal defects, one of the most common human congenital heart anomalies. Because the ventricular septum forms through the integration of multiple cell lineages and signaling centers, it has become a paradigm for studying how compartment boundaries and transcription factor networks control organ patterning. Researchers studying GO:0060412 aim to identify the genes, signaling pathways, and cellular behaviors that build this structure, and to understand how their perturbation leads to disease. The term is therefore central to developmental biology, pediatric cardiology, and regenerative medicine, and it provides a rigorous framework for interpreting genetic and imaging data from animal models and human patients.
ventricular septum morphogenesis At A Glance
| GO ID | GO:0060412 |
|---|---|
| GO term | ventricular septum morphogenesis |
| Ontology | biological_process |
| Synonym | interventricular septum morphogenesis |
| Major function | Generation and organization of the ventricular septum that separates the left and right ventricles |
| Related anatomy | Ventricular septum, including muscular and membranous components |
| Key cell types | Myocardium, endocardium, and neural crest-derived mesenchyme |
| Associated defects | Ventricular septal defects and related congenital heart malformations |
| Model organisms | Chick embryo, mouse, and other vertebrate models |
What Is GO:0060412?
According to the Gene Ontology, GO:0060412 ventricular septum morphogenesis is the developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another. The synonym interventricular septum morphogenesis is used interchangeably. This biological process encompasses the cellular and molecular events that pattern, grow, and fuse the muscular and membranous components of the septum during embryogenesis.
Why Is ventricular septum morphogenesis Important in Cell Biology?
Ventricular septum morphogenesis is important because it establishes the anatomical separation of the systemic and pulmonary circuits, and its failure is a leading cause of congenital heart disease in humans. Understanding the genes and signaling pathways that drive this process provides direct insight into the etiology of ventricular septal defects and related malformations, and it informs prenatal diagnosis, fetal intervention, and long-term clinical management. Moreover, the ventricular septum is a model system for studying compartment boundaries, lineage specification, and tissue-tissue interactions during organogenesis.
• Ventricular septal defects are among the most common congenital heart malformations, making GO:0060412 directly clinically relevant.
• The process requires precise coordination between endocardium, myocardium, and neural crest-derived cells, providing a model for studying tissue interactions.
• Connexin43 (GJA1) deficiency in mice causes heart defects including ventricular septal abnormalities, linking gap junction communication to septation.
• Hey bHLH transcription factors are downstream effectors of Notch signaling and are required for normal ventricular septum development.
• Slit-Robo signaling has been implicated in heart development, including ventricular septation, expanding the repertoire of pathways that can be targeted.
• Fetal pulmonary valve stenosis or atresia with intact ventricular septum illustrates how ventricular septum morphogenesis intersects with valve and chamber development.
• Fetal cardiac interventions are being developed for lesions that involve the ventricular septum, highlighting translational interest in this process.
• Disrupted compartment boundaries in the developing heart can underlie abnormal cardiac patterning and congenital heart defects.
• Experimental cardiac morphogenesis studies in chick embryos have provided foundational knowledge of ventricular septum development.
• Understanding GO:0060412 supports the design of CRISPR-based models to test candidate genes and pathways.
What Happens During ventricular septum morphogenesis?
Initiation and patterning of the ventricular septum
In simple terms: The heart first sets up a boundary that tells cells where the wall between the ventricles will form.
Ventricular septum morphogenesis begins with patterning events that establish the position and orientation of the future septum. Studies in the chick embryo have shown that the ventricular septum develops through coordinated growth and folding of the myocardium, with contributions from the endocardium and extracellular matrix. Compartment boundaries within the developing heart are critical for correct patterning, and their disruption can lead to abnormal cardiac morphology and congenital heart defects.
Myocardial growth and trabeculation
In simple terms: Heart muscle cells multiply and form ridges that will eventually merge into the wall.
The muscular component of the ventricular septum arises from proliferating cardiomyocytes in the ventricular wall. Experimental cardiac morphogenesis studies in the chick have detailed how the ventricular septum grows by addition of myocardial cells and remodeling of the trabecular network. Proper myocardial growth requires signaling between the endocardium and myocardium, and disruption of these interactions can impair septation.
Endocardial and mesenchymal contributions
In simple terms: Cells lining the heart and cells that migrate into the heart help build the wall.
Endocardial cells and neural crest-derived mesenchymal cells contribute to the formation of the membranous portion of the ventricular septum. Disrupted compartment boundaries in the developing heart can alter the behavior of these cell populations and lead to congenital heart defects. The interplay between endocardium, myocardium, and neural crest is therefore essential for normal ventricular septum morphogenesis.
Signaling pathways controlling septation
In simple terms: Chemical signals tell the cells when to grow, move, and fuse to form the wall.
Several signaling pathways regulate ventricular septum morphogenesis. Hey bHLH transcription factors act downstream of Notch signaling and are required for normal cardiovascular development, including ventricular septation. Slit-Robo signaling has also been implicated in heart development and may influence septation through effects on cell migration and tissue patterning. Connexin43 (GJA1) gap junctions are required for normal heart development, and their deficiency in mice causes heart defects including ventricular septal abnormalities.
Fusion and remodeling of the septum
In simple terms: The growing wall fuses with other structures and is reshaped into its final form.
The final steps of ventricular septum morphogenesis involve fusion of the muscular and membranous components and remodeling of the septum to match the mature heart architecture. Failure of fusion or remodeling results in ventricular septal defects, which are among the most common congenital heart malformations. Fetal pulmonary valve stenosis or atresia with intact ventricular septum illustrates how septal and valvular development are intertwined.
Key Genes Involved in GO:0060412 ventricular septum morphogenesis
The following genes and proteins have been experimentally implicated in ventricular septum morphogenesis or in related congenital heart defects, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GJA1 (Connexin43) | Gap junction channel protein required for normal heart development | Connexin43-deficient mice exhibit heart defects including ventricular septal abnormalities |
| HEY1 | bHLH transcription factor downstream of Notch signaling | Hey bHLH factors are required for cardiovascular development, including ventricular septation |
| HEY2 | bHLH transcription factor downstream of Notch signaling | Hey bHLH factors are required for cardiovascular development, including ventricular septation |
| SLIT2 | Secreted ligand for Robo receptors | Slit-Robo signaling is implicated in heart development and septation |
| ROBO1 | Receptor for Slit ligands | Slit-Robo signaling is implicated in heart development and septation |
| ROBO2 | Receptor for Slit ligands | Slit-Robo signaling is implicated in heart development and septation |
| NKX2-5 | Cardiac transcription factor | Associated with congenital heart defects including ventricular septal defects |
| TBX5 | Cardiac transcription factor | Associated with congenital heart defects including ventricular septal defects |
| GATA4 | Cardiac transcription factor | Associated with congenital heart defects including ventricular septal defects |
| TBX1 | Transcription factor involved in outflow tract and septation | Associated with congenital heart defects including ventricular septal defects |
| MEF2C | Cardiac transcription factor | Associated with cardiac development and septation |
| HAND1 | Cardiac transcription factor | Associated with cardiac development and septation |
| HAND2 | Cardiac transcription factor | Associated with cardiac development and septation |
| NOTCH1 | Receptor in Notch signaling pathway | Notch signaling influences Hey bHLH factors and cardiovascular development |
| JAG1 | Notch ligand | Notch signaling influences Hey bHLH factors and cardiovascular development |
| DLL4 | Notch ligand | Notch signaling influences Hey bHLH factors and cardiovascular development |
How Is ventricular septum morphogenesis Regulated?
Ventricular septum morphogenesis is regulated by a combination of transcriptional networks and intercellular signaling pathways. Hey bHLH transcription factors act downstream of Notch signaling and are required for normal cardiovascular development, including ventricular septation. Slit-Robo signaling has been implicated in heart development and may regulate cell migration and tissue patterning during septation. Connexin43 (GJA1) gap junctions are required for normal heart development, and their deficiency in mice causes heart defects including ventricular septal abnormalities. Compartment boundaries within the developing heart are also critical for correct patterning, and their disruption can lead to congenital heart defects.
ventricular septum morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GJA1 | Heart defects including ventricular septal abnormalities | Knockout mouse |
| HEY1/HEY2 | Congenital heart defects related to Notch signaling | Conditional knockout mouse |
| SLIT2/ROBO1/ROBO2 | Abnormal heart development and septation | Knockout or overexpression models |
| NKX2-5 | Congenital heart defects including VSD | Knock-in or knockout models |
| TBX5 | Congenital heart defects including VSD | Knock-in or knockout models |
Ventricular septal defects
Ventricular septal defects (VSDs) are among the most common congenital heart malformations and result from failure of ventricular septum morphogenesis. They can occur as isolated lesions or as part of complex syndromes, and their clinical presentation ranges from asymptomatic murmurs to heart failure. Fetal pulmonary valve stenosis or atresia with intact ventricular septum illustrates how septal and valvular abnormalities can coexist and influence outcome.
Connexin43 deficiency and heart defects
Mice deficient in connexin43 (GJA1) exhibit heart defects, including abnormalities of the ventricular septum, demonstrating that gap junction communication is required for normal cardiac morphogenesis. This links GO:0060412 to arrhythmia and structural heart disease research.
Notch signaling and congenital heart disease
Hey bHLH transcription factors, which are downstream of Notch signaling, are required for normal cardiovascular development, and their dysfunction has been associated with congenital heart defects. This places Notch-Hey signaling within the regulatory network of ventricular septum morphogenesis.
Fetal cardiac interventions
Fetal cardiac interventions are being developed for lesions that involve the ventricular septum, such as pulmonary valve stenosis or atresia with intact ventricular septum. These approaches highlight the translational importance of understanding ventricular septum morphogenesis for prenatal diagnosis and therapy.
From ventricular septum morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene cause ventricular septal defects? | Knockout mouse or chick embryo |
| Does a specific point mutation in a cardiac transcription factor alter septation? | Point-mutation knock-in mouse |
| Can a human variant rescue septation in a model organism? | Knock-in of human variant |
| Where and when is a candidate protein expressed during septation? | Tagged knock-in with fluorescent reporter |
| Does overexpression of a signaling ligand disrupt septation? | Transgenic overexpression model |
| Can fetal intervention prevent progression of septal defects? | Fetal cardiac intervention models |
How to Study the ventricular septum morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Embryonic imaging | Morphology and cell movements during septation | Visualizing ventricular septum development |
| Lineage tracing | Origin and fate of cells contributing to the septum | Identifying myocardial, endocardial, and neural crest contributions |
| Knockout mouse | Requirement of a gene for septation | Testing candidate genes such as GJA1 |
| Conditional mutagenesis | Tissue-specific gene function | Dissecting Notch-Hey signaling in the heart |
| Signaling pathway assays | Activity of Notch, Slit-Robo, and other pathways | Mechanistic studies of septation |
| Human genetics | Association of variants with ventricular septal defects | Clinical correlation and gene discovery |
| Fetal echocardiography | Structure and function of the fetal heart | Diagnosis and monitoring of septal defects |
Embryonic imaging and lineage tracing
Imaging of the developing heart in chick and mouse embryos has been used to visualize ventricular septum morphogenesis and to trace the contributions of different cell lineages. These methods reveal how myocardial, endocardial, and neural crest-derived cells coordinate to build the septum.
Genetic knockout and conditional mutagenesis
Knockout and conditional mutagenesis in mice have been used to test the requirement for specific genes in ventricular septum morphogenesis. For example, connexin43-deficient mice exhibit heart defects including ventricular septal abnormalities, and Hey bHLH factors are required for cardiovascular development.
Signaling pathway analysis
Analysis of signaling pathways such as Notch-Hey and Slit-Robo has provided insight into the molecular control of ventricular septum morphogenesis. These studies use biochemical assays, reporter lines, and pathway inhibitors to dissect mechanism.
Human genetics and clinical correlation
Human genetic studies and clinical series have linked mutations in cardiac transcription factors and other genes to ventricular septal defects and related congenital heart disease. These findings help translate experimental results into clinical understanding.
How CRISPR Can Be Used to Study GO:0060412 ventricular septum morphogenesis
Knockout
CRISPR knockout can be used to delete candidate genes in cell models or animal models to test their requirement for ventricular septum morphogenesis. For example, knockout of GJA1 in mice causes heart defects including ventricular septal abnormalities, and similar approaches can be applied to other genes identified from human genetics.
Point Mutation
CRISPR point mutation can introduce specific patient-derived variants into endogenous loci to test whether they alter septation. This is particularly useful for cardiac transcription factors such as NKX2-5, TBX5, and GATA4, where missense mutations have been associated with congenital heart defects.
Knock-in
CRISPR knock-in can be used to tag endogenous proteins with fluorescent reporters or to humanize a locus by replacing a mouse gene with its human ortholog. These models allow visualization of protein expression during ventricular septum morphogenesis and functional testing of human variants.
Overexpression
CRISPR overexpression, for example via CRISPR activation, can be used to increase the expression of signaling ligands such as SLIT2 or Notch components to test whether excess signaling disrupts septation. This complements loss-of-function approaches and helps define the dose-sensitive nature of septation pathways.
How EDITGENE Supports ventricular septum morphogenesis Research
Researchers studying ventricular septum morphogenesis-related genes often need to determine whether a candidate gene is causally involved in septation, whether a specific variant is pathogenic, and how the gene product behaves in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from knockout and point mutation to knock-in, overexpression, library screening, and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for ventricular septum morphogenesis research.
Frequently Asked Questions About ventricular septum morphogenesis
What is GO:0060412 ventricular septum morphogenesis?
GO:0060412 is the Gene Ontology biological process describing the developmental process in which a ventricular septum is generated and organized, separating the lower chambers of the heart.
What genes are involved in ventricular septum morphogenesis?
Genes implicated in this process include GJA1 (connexin43), HEY1, HEY2, SLIT2, ROBO1, ROBO2, NKX2-5, TBX5, GATA4, and others.
What happens when ventricular septum morphogenesis fails?
Failure of ventricular septum morphogenesis results in ventricular septal defects, which are among the most common congenital heart malformations.
How is ventricular septum morphogenesis studied in animal models?
It is studied using chick and mouse embryos, lineage tracing, knockout and conditional mutagenesis, and imaging of the developing heart.
What is the role of connexin43 in ventricular septum morphogenesis?
Connexin43 (GJA1) gap junctions are required for normal heart development, and connexin43-deficient mice exhibit heart defects including ventricular septal abnormalities.
How does Notch signaling affect ventricular septum morphogenesis?
Hey bHLH transcription factors downstream of Notch signaling are required for normal cardiovascular development, including ventricular septation.
What is the relationship between Slit-Robo signaling and heart development?
Slit-Robo signaling has been implicated in heart development, including processes relevant to ventricular septation.
Can CRISPR be used to study ventricular septum morphogenesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to test candidate genes and variants in septation research.
What are ventricular septal defects?
Ventricular septal defects are congenital heart malformations caused by failure of the ventricular septum to form completely, leading to a shunt between the ventricles.
Why is fetal cardiac intervention relevant to ventricular septum morphogenesis?
Fetal cardiac interventions are being developed for lesions involving the ventricular septum, such as pulmonary valve stenosis or atresia with intact ventricular septum, highlighting the clinical importance of this process.
Conclusion
GO:0060412 ventricular septum morphogenesis is a fundamental developmental process that builds the wall separating the heart's ventricles. Its disruption causes ventricular septal defects and related congenital heart disease, making it a key focus for developmental biologists and clinicians. Research using animal models and CRISPR-based approaches continues to identify the genes and signaling pathways that control septation, offering hope for improved diagnosis and therapy.
References
- 1. Roman KS et al.. 2007. Determinants of outcome in fetal pulmonary valve stenosis or atresia with intact ventricular septum.. Am J Cardiol 99(5):699-703 PMID: 17317375
- 2. Zhao J et al.. 2018. Slit-Robo signalling in heart development.. Cardiovasc Res 114(6):794-804 PMID: 29538649
- 3. Harh JY et al.. 1975. Experimental cardiac morphogenesis. I. Development of the ventricular septum in the chick.. J Embryol Exp Morphol 33(1):13-28 PMID: 1151263
- 5. Weber D et al.. 2014. Hey bHLH transcription factors.. Curr Top Dev Biol 110:285-315 PMID: 25248480
- 6. Friedman KG et al.. 2020. Fetal cardiac interventions: Where do we stand?. Arch Cardiovasc Dis 113(2):121-128 PMID: 32113817
- 7. Kathiriya IS et al.. 2026. A disrupted compartment boundary underlies abnormal cardiac patterning and congenital heart defects.. Nat Cardiovasc Res 5(1):67-83 PMID: 41461901
- 8. Ya J et al.. 1998. Heart defects in connexin43-deficient mice.. Circ Res 82(3):360-6 PMID: 9486664
